In this free webinar, gain insight into the key elements to reduce risk for clinical trials. Attendees will learn how Independent Review and Data Analytics in eCOA strengthen endpoint integrity and ...

Pfizer and Bristol-Myers Squibb (BMS) recently raised questions with and sought further clarity from the US Food and Drug Administration (FDA) on a draft guidance related to the risk-based monitoring ...

Following the release of five guidances to broaden cancer clinical trial eligibility earlier this week, the US Food and Drug Administration (FDA) is out with draft guidance Thursday on the risk-based ...

This post is sponsored by IMARC Research, Inc. Since the August 2011 release of the draft guidance document by the FDA on a risk-based approach to monitoring, there has been a lot of buzz in the ...

Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions. For ...

The American Gastroenterology Association (AGA) Institute issued new clinical practice guidelines, providing evidence-based recommendations for managing hepatitis B reactivation (HBVr) in at-risk ...

David Benigson is CEO of Signal AI, a company using AI and media data to help executives cut through noise and drive actionable insights. Risk is no longer a four-letter word—it's a critical factor ...

Nathan Eddy works as an independent filmmaker and journalist based in Berlin, specializing in architecture, business technology and IT. He is a graduate of Northwestern University’s Medill School of ...